The Preclinical Imaging Market is benefiting from continued investment in disease research, with oncology remaining a leading application area. Market Research Future reports that oncology represented 42.3% of the market in 2025, while neurology applications are forecast to expand at a 10.7% CAGR from 2026 to 2035.

The strong position of oncology is connected with expanding immuno-oncology research and the development of new therapeutic candidates. Imaging technologies can help researchers monitor tumor development and treatment response over time, supporting more detailed evaluation during preclinical programs.

Neurology is emerging as another significant growth opportunity. Increasing research into Alzheimer's disease and other neurodegenerative conditions is encouraging demand for imaging technologies capable of examining neurological structures and biological changes. Micro-MRI and other advanced modalities can support these increasingly sophisticated research programs.

The expansion of cell-therapy and radiopharmaceutical pipelines is also broadening applications. Imaging can contribute to studies of biodistribution, dosimetry, and therapeutic response, making advanced modalities increasingly relevant to emerging treatment-development programs.

As research programs become more specialized, suppliers are expected to focus on application-specific imaging platforms and analytical software. Companies that can combine high-quality imaging with automated quantification and longitudinal data analysis may find opportunities across oncology, neurology, immunology, and advanced therapy research.

Strengthen your strategy with data-backed research insights:

Coronary Stents Market Share

Drug Discovery Services Market Trends

Knee Replacement Market Growth

Genomics Market Demand

In Vitro Fertilization Market Volume